clx: the income statement

MyFinsight

For the quarter ending 2025-09-30, CLX made $1,429M in revenue. $80M in net income. Net profit margin of 5.60%.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-03-31	2024-12-31	2024-09-30
Net sales	1,429	1,668	1,686	1,762
Cost of products sold	833	924	948	955
Gross profit	596	744	738	807
Selling and administrative expenses	277	267	280	281
Advertising costs	166	207	191	201
Research and development costs	28	27	31	31
Loss on divestiture	0	0	0	-118
Pension settlement charge	-	0	0	-
Interest expense	23	23	22	21
Amortization of trademarks and other intangible assets	-	5	-	-
Trust investment (gains) losses, net	-	-2	-	-
Net periodic benefit cost	-	3	-	-
Foreign exchange transaction (gains) losses, net	-	1	-	-
Income from equity investees	-	0	-	-
Interest income	-	2	-	-
Restructuring costs	-	0	-	-
Gain on sale-leaseback transaction	-	0	-	-
Cyberattack insurance recoveries	-	33	-	-
Other	-	-8	-	-
Other (income) expense, net	-5	-34	-23	-22
Earnings before income taxes	107	254	237	177
Income tax expense	25	63	43	74
Net earnings	82	191	194	103
Less net earnings attributable to noncontrolling interests	2	5	1	4
Net earnings attributable to clorox	80	186	193	99

Basic (in shares)	122,629,000	123,367,000	123,766,000	123,795,000
Basic net earnings per share (in dollars per share)	0.65	1.51	1.55	0.8
Diluted (in shares)	123,018,000	124,066,000	124,662,000	124,677,000
Diluted net earnings per share (in dollars per share)	0.65	1.5	1.54	0.8